Thread re: retraction of the FLCCC paper from the Journal of Intensive Care Medicine
It is unfortunate that JICM retracted an entire paper based on their refusal to accept an update to 1 section of data that had little relevance to the focus or conclusions of the paper (1/8)
This was a comprehensive paper - 13 sections, nearly 200 scientific references detailing the science behind each MATH+ element of the 2020 protocol. The data in question was in 1 section and WAS ACCURATE when we originally submitted- i.e. a 6% COVID mortality at Sentara (2/8)
After peer-review & publication, a very unusual request came to us from JICM. Sentara Hospital asked the journal that the paper be updated with longer-term follow up data calculated differently (they never said our original data was inaccurate). (3/8)
Using Sentara's method, they came up with a 10% mortality - STILL FAR LESS than the 23% U.S hospital mortality average average we were loosely comparing it to. (4/8)
Best part: Sentara, in their ignorance, tried to call out the 28% mortality of patients who got all components of MATH+ as if it was a bad thing - without realizing those were ICU patients at a time when U.S institutions were reporting UP TO AN 88% MORTALITY in the ICU (5/8)
We then provided the only follow-up data we had - JICM refused to accept. We then offered to retract the entire section with the old Sentara data - JICM refused. The conclusion of the paper (it was a RATIONALE paper) still stands without the Sentara data even being included. 6/8
This action by the journal puts the FLCCC again on the growing list of scientists whose peer reviewed manuscripts on repurposed drugs have been retracted by editors throughout the pandemic (after passing peer review!). (7/8)
If medical research is there just to serve in supporting mainstream collective thinking and censor those who might have alternative approaches or differing interpretations, the future of medicine will be very dark. (8/8)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Pierre Kory, MD MPA

Pierre Kory, MD MPA Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @PierreKory

15 Sep
🧵How long can the Alphabet Agencies and Ivory Towers fight the massive & rising real world data of IVM rapidly stopping &/or preventing COVID surges? It's gonna be a looong walk back from that position man - I would be starting that $%&! walk now (1/5)

bit.ly/3hy80XF
2/5 - and Mexico City's Health Dept report of their early treatment program comparing the over 50,000 ppl treated with IVM and the over 70,000 who didn't... Massive 60-75% reduction in need for hospital, helping empty them over 6-12 weeks bit.ly/3liGuOM (2/5)
3/5 - and the Health Ministry of La Pampa, Argentina report on their IVM early Rx program which found 40% less hospitalization and 35% less ICU or death.. insane
bit.ly/3zg01o6 (3/5)
Read 5 tweets
6 Sep
1/6 🧵Now lets talk about the #$%! captured medical journals. High impact ones will ONLY publish studies that although they show benefit, don't meet statistical significance. Then they write stuff like "this does not support the use of IVM in COVID" jamanetwork.com/journals/jama/…
2/6 Meanwhile, so much unprecedented crazy shit has happened in journals to positive studies of IVM and other repurporsed drugs it is INSANE. First, know that in the FLCCC's over 100 year academic career (1500 papers), never has any been retracted after passing peer review..
3/6 Here we go:
1) Frontiers in pharmacology (funded by BMGF) retracted our paper... AFTER passing rigorous peer review
1a) They then retract other accepted repurposed drug papers.. editors quit en masse
2) Lancet Respiratory retracted Bryant meta-analysis..AFTER peer review
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(